Denali Therapeutics Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$21.86 | $1.59 B | -7.1 | 60 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$27.66 | $4.90 B | -11.77 | 702 | $396.59 M |
ASND
Ascendis Pharma A/S |
$131.98 | $7.77 B | -14.19 | 879 | $266.72 M |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.25 | $291.95 M | -3.13 | 54 | $0 |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$102.54 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$11.15 | $1.12 B | -5.11 | 174 | $0 |
DSGN
Design Therapeutics, Inc. |
$4.02 | $217.51 M | -3.7 | 54 | $0 |
FDMT
4D Molecular Therapeutics, Inc. |
$4.88 | $1.17 B | -9.63 | 147 | $20.72 M |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.35 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.51 | $84.45 M | -1.11 | 14 | $9.16 M |
LEGN
Legend Biotech Corporation |
$31.66 | $8.31 B | -17.66 | 2400 | $285.14 M |
PCVX
Vaxcyte, Inc. |
$78.16 | $7.72 B | -16.54 | 254 | $0 |
RNA
Avidity Biosciences, Inc. |
$27.03 | $2.54 B | -8.99 | 253 | $9.56 M |
RVMD
Revolution Medicines, Inc. |
$39.79 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$8.66 | $774.50 M | -6.14 | 110 | $8.78 M |
SWTX
SpringWorks Therapeutics, Inc. |
$32.49 | $2.98 B | -7.81 | 305 | $5.45 M |
TVTX
Travere Therapeutics, Inc. |
$17.08 | $542.80 M | -1.32 | 380 | $145.24 M |